MedPath

A study to compare the effect of microneedling with 2 medications, Tranexamic acid and Vitamin C, for reducing the skin pigmentation in patients with melasma.

Phase 3
Conditions
Health Condition 1: L811- Chloasma
Registration Number
CTRI/2024/07/071158
Lead Sponsor
Varsha Reddy Parupati
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Females aged 18 years and above with Melasma over bilateral sides of the face.

Exclusion Criteria

Male gender.

Pregnant women, breastfeeding mothers.

History of use of oral contraceptive pills or hormone replacement therapy in the past 12 months or during the study.

History of coagulation disorders and thrombotic problems.

History of use of topical depigmenting agents within the last 60 days of the study.

Presence of active infection over the face.

Presence of keloidal tendency.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath